Age: 56.0
Sex: F
Vaccine: COVID19, FLUX
Symptoms: Headache, Vaccination site erythema, Vaccination site pruritus, Vaccination site rash, Vaccination site swelling
Clinical narrative: little bit of swelling; there's no rash on the outside of the arm, everything whatever is happening is happening on the inside; headache; hot to touch; Itching; patient saw redness; This spontaneous case was reported by a pharmacist and describes the occurrence of VACCINATION SITE WARMTH (hot to touch), VACCINATION SITE PRURITUS (Itching), VACCINATION SITE ERYTHEMA (patient saw redness), VACCINATION SITE SWELLING (little bit of swelling) and HEADACHE (headache) in a 56-year-old female patient who received mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) (batch no. 3042646) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product INFLUENZA VACCINE (FLU [INFLUENZA VACCINE]) for an unknown indication.    Previously administered products included for Product used for unknown indication: pfizer in 2023; for COVID-19 prophylaxis: moderna in 2023. Past adverse reactions to the above products included No adverse effect with moderna and pfizer. Concurrent medical conditions included Latex allergy, Penicillin allergy, Blood pressure, Mood disorder (patient was on mood medication.), Cholesterol and Inflammation (Patient was on anti inflammatories.).   On 10-Sep-2024, the patient received dose of mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) (unknown route) 1 dosage form and dose of INFLUENZA VACCINE (FLU [INFLUENZA VACCINE]) (unknown route) 1 dosage form. On 11-Sep-2024, the patient experienced VACCINATION SITE WARMTH (hot to touch), VACCINATION SITE PRURITUS (Itching), VACCINATION SITE ERYTHEMA (patient saw redness) and HEADACHE (headache). On 13-Sep-2024, the patient experienced VACCINATION SITE SWELLING (little bit of swelling) and VACCINATION SITE RASH (there's no rash on the outside of the arm, everything whatever is happening is happening on the inside). At the time of the report, VACCINATION SITE WARMTH (hot to touch), VACCINATION SITE PRURITUS (Itching), VACCINATION SITE ERYTHEMA (patient saw redness), VACCINATION SITE SWELLING (little bit of swelling), HEADACHE (headache) and VACCINATION SITE RASH (there's no rash on the outside of the arm, everything whatever is happening is happening on the inside) had not resolved.        For mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) (Unknown), the reporter did not provide any causality assessments.    The patient had received other vaccines in the 4 weeks prior to COVID-19 vaccine. Concomitant product was reported as unspecified mood medication. We administered the Moderna vaccine in the left deltoid muscle on Tuesday and the next day was 11th Sep, Wednesday and the patient saw redness and, it was hot to touch, it was, itching and, and on Friday. a few days later, day three, it's still the same way and there's a little bit of swelling, there's no rash on the outside of the arm, everything whatever was happening was happening on the inside. She feels fine. She had a headache the day after she got the flu shot and the Moderna vaccine on the same day and two different arms and the, so the right arm was fine. No problem. That's where she got the flu shot. The left arm was where she got the Moderna shot. There she had a procedure coming up next week and basically it's injecting Botox into the abdomen. She had been icing it last two days and it hadn't really changed anything. Reporter causality was not reported.